Santaris Pharma - Articles and news items

Roche logo

Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines

Industry news / 5 August 2014 / Roche

Roche announced that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark…

Novel antisense drugs for micro-RNA therapeutics

Issue 4 2006, Past issues / 20 July 2006 / Sakari Kauppinen, Joacim Elmen and Phil Kearney, Santaris Pharma

MicroRNAs (miRNAs) are an abundant class of short endogenous RNAs that act as important post-transcriptional regulators of gene expression.


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...